J. S. Smolen

Publication List Details

Period

1997 - 2005

Number

24

Co-Authors

Minimal disease activity for rheumatoid arthritis: A preliminary definition (2005)

Wells, G. A., Boers, M., Shea, B., Brooks, P. M., Simon, L. S., Strand, C. V., ...

Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization and interpretation of clinical trial reports. With recent advances in therapy, the proportion of...

Minimal disease activity for rheumatoid arthritis: A preliminary definition (2005)

Wells, G. A., Boers, M., Shea, B., Brooks, P. M., Simon, L. S., Strand, C. V., ...

Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization and interpretation of clinical trial reports. With recent advances in therapy, the proportion of...

Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNF alpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004 (2004)

Furst, Daniel E, Breedveld, F C, Kalden, J R, Smolen, J S, Burmester, G R, Bijlsma, JWJ, ...

As in previous years, the consensus group to consider the use of biological agents was constituted by rheumatologists from the Universities of Erlangen, Leiden, and Vienna in Europe in cooperation...

Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT) (2001)

Swaak, A.J., Moutsopoulos, H.M., Dratwianka, B., Kalden, J.R., Tosi, S., Marchesoni, A., ...

OBJECTIVE: Patients characterized with antinuclear antibodies (ANA) and disease symptoms related to one organ system can be described as having incomplete systemic lupus erythematosus (SLE). The aim...

Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation (1999)

Swaak, A.J., Rozman, B., Chwalinska-Sadowska, H, Bombardieri, S., Kovacs, A., Schneider, M., ...

OBJECTIVE: Most information available about the disease course of patients with systemic lupus erythematosus (SLE) is restricted to the first 5 yr after disease onset. Data about the disease course...

Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex.

Steiner, G, Hartmuth, K, Skriner, K, Maurer-Fogy, I, Sinski, A, Thalmann, E, ...

RA33 is a nuclear autoantigen with an apparent molecular mass of 33 kD. Autoantibodies against RA33 are found in about 30% of sera from RA patients, but only occasionally in sera from patients with...

Responder cells in the human autologous mixed lymphocyte reaction.

Smolen, J S, Luger, T A, Chused, T M, Steinberg, A D

Isolated human T4+ cells proliferate in the autologous mixed lymphocyte reaction (AMLR), whereas isolated T8+ cells do not. However, in the presence of Interleukin 2 or T4+ cells, the T8+ cells...

Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture.

Luger, T A, Smolen, J S, Chused, T M, Steinberg, A D, Oppenheim, J J

In this study, we demonstrate that both highly purified T4+ and T8+ lymphocytes can produce substantial amounts of Interleukin 2(IL 2) when stimulated with the combination of concanavalin A (Con A)...

Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex.

Steiner, G, Hartmuth, K, Skriner, K, Maurer-Fogy, I, Sinski, A, Thalmann, E, ...

RA33 is a nuclear autoantigen with an apparent molecular mass of 33 kD. Autoantibodies against RA33 are found in about 30% of sera from RA patients, but only occasionally in sera from patients with...

Responder cells in the human autologous mixed lymphocyte reaction.

Smolen, J S, Luger, T A, Chused, T M, Steinberg, A D

Isolated human T4+ cells proliferate in the autologous mixed lymphocyte reaction (AMLR), whereas isolated T8+ cells do not. However, in the presence of Interleukin 2 or T4+ cells, the T8+ cells...

Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture.

Luger, T A, Smolen, J S, Chused, T M, Steinberg, A D, Oppenheim, J J

In this study, we demonstrate that both highly purified T4+ and T8+ lymphocytes can produce substantial amounts of Interleukin 2(IL 2) when stimulated with the combination of concanavalin A (Con A)...

HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens.

Smolen, J S, Klippel, J H, Penner, E, Reichlin, M, Steinberg, A D, Chused, T M, ...

HLA-DR antigens and autoantibodies to the nuclear or cytoplasmic antigens Ro/SSA, La/SSB, Sm, and RNP were determined in North American and Austrian patients with systemic lupus erythematosus (SLE)....

Serum osteocalcin concentrations in patients with rheumatoid arthritis.

Pietschmann, P, Machold, K P, Wolosczuk, W, Smolen, J S

Osteocalcin is a non-collagenous bone matrix protein which is released into the circulation and can be measured by radioimmunoassay. Recent studies indicate that serum osteocalcin concentrations are...

Recombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study.

Machold, K P, Neumann, K, Smolen, J S

Interferon gamma (IFN gamma) has been advocated in open studies as a beneficial remission inducing drug for the treatment of rheumatoid arthritis (RA). The work reported here was designed to assess...

Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome.

Vitali, C, Bombardieri, S, Moutsopoulos, H M, Coll, J, Gerli, R, Hatron, P Y, ...

OBJECTIVE: To assess the recently proposed preliminary criteria for the classification of Sjögren's syndrome (SS) in a multicentre European study of a new series of clinically defined cases....

Induction of interleukin 2 receptiveness and proliferation in resting peripheral T cells by monoclonal anti-CD3 (T3) antibodies does not require the presence of macrophages.

Stingl, L A, Sinska, A, Landesmann, U, Smolen, J S

In this study, we sought to elucidate the sequence of events by which mitogenic monoclonal anti-CD3 antibodies (anti-CD3-MoAb) initiate T cell activation. In cultures of monocyte-depleted resting T...

Similar frequency of autoantibodies against 70-kD class heat-shock proteins in healthy subjects and systemic lupus erythematosus patients.

Kindås-Mügge, I, Steiner, G, Smolen, J S

Stress or heat-shock proteins may be involved in the initiation and perpetuation of autoimmune diseases. In order to investigate a possible role of autoantibodies against the 70-kD family of...

Functional and molecular aspects of transient T cell unresponsiveness: role of selective interleukin-2 deficiency

KÖLLER, M D, KIENER, H P, ARINGER, M, GRANINGER, W B, MEUER, S, SAMSTAG, Y, ...

Defects of T cell (Tc) proliferation have been demonstrated in several autoimmune diseases. Detailed mechanisms governing activation and proliferation of Tc are still not completely known. Here we...